138 related articles for article (PubMed ID: 38746303)
1. Colorectal ALOX15 as a host factor determinant of EPA and DHA effects on colorectal carcinogenesis.
Zuo X; Kiyasu Y; Liu Y; Deguchi Y; Liu F; Moussalli M; Tan L; Wei B; Wei D; Yang P; Shureiqi I
bioRxiv; 2024 May; ():. PubMed ID: 38746303
[TBL] [Abstract][Full Text] [Related]
2. EPA, DHA, and resolvin effects on cancer risk: The underexplored mechanisms.
Kiyasu Y; Zuo X; Liu Y; Yao JC; Shureiqi I
Prostaglandins Other Lipid Mediat; 2024 May; 174():106854. PubMed ID: 38825147
[TBL] [Abstract][Full Text] [Related]
3. Docosahexaenoic acid induces an anti-inflammatory profile in lipopolysaccharide-stimulated human THP-1 macrophages more effectively than eicosapentaenoic acid.
Weldon SM; Mullen AC; Loscher CE; Hurley LA; Roche HM
J Nutr Biochem; 2007 Apr; 18(4):250-8. PubMed ID: 16781858
[TBL] [Abstract][Full Text] [Related]
4. Similar eicosapentaenoic acid and docosahexaenoic acid plasma levels achieved with fish oil or krill oil in a randomized double-blind four-week bioavailability study.
Yurko-Mauro K; Kralovec J; Bailey-Hall E; Smeberg V; Stark JG; Salem N
Lipids Health Dis; 2015 Sep; 14():99. PubMed ID: 26328782
[TBL] [Abstract][Full Text] [Related]
5. Omega-3 polyunsaturated fatty acids inhibit the increase in cytokines and chemotactic factors induced in vitro by lymph fluid from an intestinal ischemia-reperfusion injury model.
Zhang R; He GZ; Wang YK; Zhou KG; Ma EL
Nutrition; 2015 Mar; 31(3):508-14. PubMed ID: 25701342
[TBL] [Abstract][Full Text] [Related]
6. In vitro effects of docosahexaenoic and eicosapentaenoic acid on human meibomian gland epithelial cells.
Hampel U; Krüger M; Kunnen C; Garreis F; Willcox M; Paulsen F
Exp Eye Res; 2015 Nov; 140():139-148. PubMed ID: 26335632
[TBL] [Abstract][Full Text] [Related]
7. Mammalian ALOX15 orthologs exhibit pronounced dual positional specificity with docosahexaenoic acid.
Kutzner L; Goloshchapova K; Heydeck D; Stehling S; Kuhn H; Schebb NH
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Jul; 1862(7):666-675. PubMed ID: 28400162
[TBL] [Abstract][Full Text] [Related]
8. Identification of inflammatory and proresolving lipid mediators in bone marrow and their lipidomic profiles with ovariectomy and omega-3 intake.
Poulsen RC; Gotlinger KH; Serhan CN; Kruger MC
Am J Hematol; 2008 Jun; 83(6):437-45. PubMed ID: 18429055
[TBL] [Abstract][Full Text] [Related]
9. Omega-3 polyunsaturated fatty acids suppress the inflammatory responses of lipopolysaccharide-stimulated mouse microglia by activating SIRT1 pathways.
Inoue T; Tanaka M; Masuda S; Ohue-Kitano R; Yamakage H; Muranaka K; Wada H; Kusakabe T; Shimatsu A; Hasegawa K; Satoh-Asahara N
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 May; 1862(5):552-560. PubMed ID: 28254441
[TBL] [Abstract][Full Text] [Related]
10. Over-the-counter fish oil supplementation and pro-resolving and pro-inflammatory lipid mediators in rheumatoid arthritis.
Marchand NE; Choi MY; Oakes EG; Cook NR; Stevens E; Gomelskaya N; Kotler G; Manson JE; Lasky-Su J; Mora S; Lee IM; Tatituri R; Costenbader KH
Prostaglandins Leukot Essent Fatty Acids; 2023 Mar; 190():102542. PubMed ID: 36773395
[TBL] [Abstract][Full Text] [Related]
11. Omega-3 Fatty Acid Formulations in Cardiovascular Disease: Dietary Supplements are Not Substitutes for Prescription Products.
Fialkow J
Am J Cardiovasc Drugs; 2016 Aug; 16(4):229-239. PubMed ID: 27138439
[TBL] [Abstract][Full Text] [Related]
12. Omega-3 Polyunsaturated Fatty Acid Eicosapentaenoic Acid or Docosahexaenoic Acid Improved Ageing-Associated Cognitive Decline by Regulating Glial Polarization.
Xia J; Yang L; Huang C; Deng S; Yang Z; Zhang Y; Zhang C; Song C
Mar Drugs; 2023 Jul; 21(7):. PubMed ID: 37504929
[TBL] [Abstract][Full Text] [Related]
13. Treatment of LS174T colorectal cancer stem-like cells with n-3 PUFAs induces growth suppression through inhibition of survivin expression and induction of caspase-3 activation.
Sam MR; Ahangar P; Nejati V; Habibian R
Cell Oncol (Dordr); 2016 Feb; 39(1):69-77. PubMed ID: 26671842
[TBL] [Abstract][Full Text] [Related]
14. ALOX15 as a suppressor of inflammation and cancer: Lost in the link.
Tian R; Zuo X; Jaoude J; Mao F; Colby J; Shureiqi I
Prostaglandins Other Lipid Mediat; 2017 Sep; 132():77-83. PubMed ID: 28089732
[TBL] [Abstract][Full Text] [Related]
15. Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and their mechanisms of action on apolipoprotein B-containing lipoproteins in humans: a review.
Oscarsson J; Hurt-Camejo E
Lipids Health Dis; 2017 Aug; 16(1):149. PubMed ID: 28797250
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Omega-3 Eicosapentaenoic Acid Versus Docosahexaenoic Acid-Rich Fish Oil Supplementation on Plasma Lipids and Lipoproteins in Normolipidemic Adults.
Yang ZH; Amar M; Sampson M; Courville AB; Sorokin AV; Gordon SM; Aponte AM; Stagliano M; Playford MP; Fu YP; Yang S; Mehta NN; Remaley AT
Nutrients; 2020 Mar; 12(3):. PubMed ID: 32178279
[TBL] [Abstract][Full Text] [Related]
17. Omega-3 fatty acids and inflammatory processes: from molecules to man.
Calder PC
Biochem Soc Trans; 2017 Oct; 45(5):1105-1115. PubMed ID: 28900017
[TBL] [Abstract][Full Text] [Related]
18. Risk stratification by the "EPA+DHA level" and the "EPA/AA ratio" focus on anti-inflammatory and antiarrhythmogenic effects of long-chain omega-3 fatty acids.
Rupp H; Wagner D; Rupp T; Schulte LM; Maisch B
Herz; 2004 Nov; 29(7):673-85. PubMed ID: 15580322
[TBL] [Abstract][Full Text] [Related]
19. Effects of docosahexaenoic acid-rich n-3 fatty acid supplementation on cytokine release from blood mononuclear leukocytes: the OmegAD study.
Vedin I; Cederholm T; Freund Levi Y; Basun H; Garlind A; Faxén Irving G; Jönhagen ME; Vessby B; Wahlund LO; Palmblad J
Am J Clin Nutr; 2008 Jun; 87(6):1616-22. PubMed ID: 18541548
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
